| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.1830141004 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830141004 |
| https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830141004 | ||
| P698 | PubMed publication ID | 6208035 |
| P50 | author | Charles Janeway | Q1065040 |
| P2093 | author name string | Tite JP | |
| P2860 | cites work | Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism | Q24679391 |
| Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas | Q30450024 | ||
| T cell-dependent activation of resting B cells: requirement for both nonspecific unrestricted and antigen-specific Ia-restricted soluble factors | Q35352169 | ||
| Dissociation of two signals required for activation of resting B cells | Q36287647 | ||
| T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views | Q36343947 | ||
| Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition | Q36344766 | ||
| Role of the major histocompatibility complex in T cell activation of B cell subpopulations Lyb-5+ and Lyb-5- B cell subpopulations differ in their requirement for major histocompatibility complex-restricted T cell recognition | Q36345428 | ||
| Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells | Q36345818 | ||
| Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells | Q36346159 | ||
| Identification of a T cell-derived b cell growth factor distinct from interleukin 2. | Q36346214 | ||
| Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing | Q36348935 | ||
| T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level | Q36360899 | ||
| Mechanism of Specific Tumor-Cell Lysis by Alloimmune T Lymphocytes: Resolution and Characterization of Discrete Steps in the Cellular Interaction | Q39863964 | ||
| Mechanisms of T cell-B cell interaction | Q40076418 | ||
| Cytolytic T lymphocytes | Q40076423 | ||
| Dendritic Cells: Features and Functions | Q40099678 | ||
| Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. | Q40105259 | ||
| Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen-Reactivity | Q40108126 | ||
| Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition | Q40676784 | ||
| The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells | Q43875470 | ||
| Evidence that the Thy-1 molecule is the target for T cell mitogenic antibody against brain-associated antigens | Q48771896 | ||
| Carrier-priming leads to hapten-specific suppression. | Q52229429 | ||
| In vivo cyclic change in B-lymphocyte susceptibility to T-cell control. | Q52229433 | ||
| The suppressive effect of carrier priming on the response to a hapten-carrier conjugate. | Q53893561 | ||
| Direct cloning and extended culture of antigen-specific MHC-restricted, proliferating T lymphocytes | Q59062330 | ||
| Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted | Q59067228 | ||
| The role of B cell surface Ia antigen recognition by T cells in B cell triggering. Analysis of the interaction of cloned helper T cells with normal B cells in differing states of activation and with B cells expressing thexid defect | Q70361979 | ||
| Lyt phenotypes of primary cytotoxic T cells generated across the A and E region of the H-2 complex | Q72092825 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 878-886 | |
| P577 | publication date | 1984-10-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognatevs. noncognate interactions in cytolysis | |
| P478 | volume | 14 |
| Q36735993 | A different outlook at the phenotype-function relationships of T cell subpopulations: Fundamental and clinical implications |
| Q42642784 | A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines |
| Q41308649 | A novel strategy for immunotherapy using antibody-coupled carriers to focus cytotoxic T helper cells |
| Q36539233 | Activation and Functions of CD4+T-Cell Subsets |
| Q37185460 | Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells |
| Q45850732 | Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. |
| Q38174136 | Antigen-major histocompatibility complex-T cell receptors: inquiries into the immunological ménage à trois |
| Q73727337 | Antigen-presenting hybridoma cells expressing MHC antigens of the LEW rat |
| Q54012377 | Antigen-specific T(h)1 cells as direct effectors of Propionibacterium acnes-primed lipopolysaccharide-induced hepatic injury. |
| Q41698255 | Atterns of Lymphokine Production by Primary Antigen-Specific/MHC Restricted Murine Helper T Cell Clones |
| Q35595889 | Autocrine growth inhibition of a cloned line of helper T cells |
| Q41356974 | Biological response modifiers (BRM) as antigens. III. T cell lines specific for BRM kill tumor cells in a BRM-specific manner |
| Q33834466 | CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection |
| Q67513111 | CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC |
| Q41732487 | CD4+ cytolytic T cell clones that recognize polymorphism of HLA-DR beta 3 chains |
| Q36350815 | Characterization of antigen-specific, Ia-restricted, L3T4+ cytolytic T lymphocytes and assessment of thymic influence on their self specificity |
| Q21296742 | Cytotoxic CD4 T cells in antiviral immunity |
| Q35595849 | DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant |
| Q41140407 | Detachment activity but not cytotoxicity induced in a T-cell clone following antigen presentation in the presence of thymic epithelial cells |
| Q36351700 | Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones |
| Q63363256 | Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent |
| Q41960332 | Differential expression of the alternatively spliced exons of murine CD45 in Th1 and Th2 cell clones |
| Q41727080 | Differential requirement for protein synthesis in cytolysis mediated by class I and class II MHC-restricted cytotoxic T cells |
| Q36351526 | Direct interactions between B and T lymphocytes bearing complementary receptors |
| Q36350297 | Distinct functional phenotypes of cloned Ia-restricted helper T cells |
| Q39659458 | Distinguishable pathways of viral antigen presentation to T lymphocytes |
| Q71815210 | Down‐modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fasligand interaction |
| Q69992954 | Effector functions and specificities of normal murine T cells stimulated by syngeneic blasts |
| Q40771367 | Elevated temperature regulates tumor necrosis factor-mediated immune killing |
| Q57275824 | Endogenous retroviral superantigen presentation by B cells induces the development of type 1 CD4+ T helper lymphocytes |
| Q72650455 | Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells |
| Q42560254 | Evidence for T Cell Help in the IgG Response against Tandemly Repetitive Trypanosoma cruzi B13 Protein in Chronic Chagas Disease Patients |
| Q36357027 | Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation |
| Q46442889 | Evidence for quantitative and qualitative differences in functional activation of MIs-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies |
| Q41814029 | Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones |
| Q51427499 | From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury. |
| Q69030297 | Generation of thyroglobulin-specific T-cell clones derived from F1 Fisher rats |
| Q34632476 | Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide |
| Q69994767 | Helper and suppressor activities of an autoreactive mouse thyroglobulin-specific T-cell clone |
| Q70013159 | Heterogeneous cytotoxic cells that kill NC-sensitive WEHI-164 tumor cells are activated in allogeneic mixed lymphocyte reactions |
| Q36353110 | Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells |
| Q34418112 | How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? |
| Q38214438 | How many ways can a killer cell kill? |
| Q59096148 | Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes |
| Q57275645 | Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules |
| Q41663946 | Igh-1b-specific CD4+CD8− T cell clones of the Th1 subset selectively suppress the Igh-1b allotypein vivo |
| Q38200062 | Immune suppression genes. |
| Q41672298 | In vitro regulation of thyroglobulin (Tg) autoantibody production by Tg-specific T-cell lines and hybridomas |
| Q87916474 | Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells |
| Q72211763 | Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice |
| Q58989784 | Killing of antigen-reactive B cells by class II- restricted, soluble antigen–specific CD8+ cytolytic T lymphocytes |
| Q44975100 | Low doses of interleukin 2 induce bystander cell lysis by antigen-specific CD4+ inflammatory T cell clones in short-term assay |
| Q54424677 | Lysis of bystander target cells after triggering of human cytotoxic T lymphocytes. |
| Q70348993 | Lysis of nonnucleated red blood cells by cytotoxic T lymphocytes |
| Q44085951 | Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype |
| Q54249391 | Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumour necrosis factor-independent nucleolytic mechanism |
| Q35532727 | Mechanisms of transplantation immunity |
| Q68083778 | Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones |
| Q33836328 | Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction |
| Q41769875 | Partial tolerance in beta-galactosidase-transgenic mice |
| Q30573918 | Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance |
| Q44044768 | Receptor-directed focusing of lymphokine release by helper T cells |
| Q39652057 | Recognition of multiple class II signals by murine T cell antigen receptors. Speculation regarding the relationships among autoreactive, antigen-specific and alloreactive T cells |
| Q56967374 | Regulation of IgG production by suppressor FcγRII+ T hybridomas |
| Q34397096 | Regulation of tumor growth by IFN-gamma in cancer immunotherapy. |
| Q72752088 | Requirement of monocytes and T-helper cells during development of tumor cell cytotoxicity in targeted T cells |
| Q36357601 | Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules |
| Q68960538 | Selective elimination through a cytolytic mechanism of bovine serum albumin-specific T helper lymphocytes by T suppressor cells with the same antigen specificity |
| Q59068434 | Serine esterase in cytolytic T lymphocytes |
| Q70331573 | Specific lysis of Listeria monocytogenes-infected macrophages by class II-restricted L3T4+ T cells |
| Q68189935 | Specific suppression of antibody responses by soluble protein-specific, class II-restricted cytolytic T lymphocyte clones |
| Q35593962 | Structural basis of antigen recognition by T lymphocytes. Implications for vaccines |
| Q36254892 | Surrogate antigen processing mediated by TAP-dependent antigenic peptide secretion |
| Q67669959 | The acquisition and maintenance of cytolytic activity by CD4+ murine T-lymphocyte clones |
| Q33836317 | The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease |
Search more.